34 Women Sue AstraZeneca Over Nexium Bone Risks

Law360, New York (May 25, 2011, 3:36 PM EDT) -- Thirty-four women accused AstraZeneca LP in Texas state court Wednesday of marketing acid reflux drug Nexium as safe when the company knew it increased bone deterioration and fractures in women.

The women claim they suffered unexpected bone breaks or bone deterioration after taking Nexium, and that AstraZeneca neglected to warn them of the drug's bone risks. AstraZeneca withheld information about these risks knowingly, according to the suit, which says that six studies since 2006 have found that Nexium and other so-called proton pump inhibitors increase the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.